Clinical Research
corporate_fare

Syneurx International (Taiwan) Corp.

Address
20f 8 No. 99, Xin Tai 5th Rd. Sec 1, Xizhi Dist.

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
4
research centres
public
1
country
person_search
4
investigators

Specializations

Psychiatry and Schizophrenia

Syneurx International (Taiwan) Corp. is involved in clinical research for adults with refractory schizophrenia, with a focus on persistent residual symptoms that remain despite treatment with clozapine.

  • Residual symptom management
  • Treatment-resistant schizophrenia
  • Adult psychiatric care

The sponsor’s research interest centers on adjunctive therapeutic options for schizophrenia within a psychiatric setting in Taiwan.

Adjunctive Neuropsychiatric Therapy

The funded study examines add-on treatment strategies alongside clozapine for patients with incomplete symptom control, reflecting a therapeutic emphasis on improving outcomes in complex neuropsychiatric disorders.

  • Add-on therapy
  • Symptom reduction
  • Antipsychotic combination treatment

This area of interest aligns with clinical needs in patients who continue to experience functional and symptomatic burden under existing antipsychotic treatment.

Central Nervous System Therapeutics

Syneurx International’s research activity also falls within central nervous system therapeutics, with attention to agents targeting neurochemical pathways relevant to persistent psychiatric symptoms.

  • D-amino acid oxidase inhibition
  • Neurochemical modulation
  • Psychiatric symptom control

The sponsor’s clinical focus includes therapies intended to address unmet needs in severe mental illness through mechanisms beyond standard antipsychotic treatment.

Multi-center Clinical Development

The company’s funded research spans multiple collaborating sites in a single-country setting, supporting clinical evaluation of treatments for psychiatric disorders in routine research environments.

  • Multi-site collaboration
  • Clinical evaluation in psychiatry
  • Therapeutic development in adults

Its clinical interests are concentrated on advancing treatment options for adults living with chronic schizophrenia symptoms.

Sponsored Trials

Trial Name Country Status
Evaluation of Sodium Benzoate as an Adjunct to Clozapine for Residual Symptoms in Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyPoland PolandRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
1
Exclusive Molecules
out of 1 total (100% not shared with other sponsors)

This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times

This sponsor has worked with 4 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Mental Disorders1 trial
    150 other sponsors

Partnered Research Centres

4 centres
location_city
assignment126
Centrum Badan Klinicznych Pi-House Sp. z o.o.
Address
Ul. Na Zaspe 3, 80-546 Gdansk
Learn morearrow_forward
location_city
assignment6
Centrum Medyczne Luxmed Sp. z o.o.
Address
Ul. Krolewska 11, 20-109 Lublin
Learn morearrow_forward
location_city
assignment1
Indywidualna Specjalistyczna Praktyka Lekarska Wiesław Jerzy Cubała
Address
2A/3 Aldony str., 80-438 Gdansk
Learn morearrow_forward
location_city
assignment1
Przychodnia Lekarsko Psychologiczna Persona Baranowski Mazurek Lekarzy sp.p.
Address
Ul. Kleczkowska 29, 50-227 Wroclaw
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Syneurx International (Taiwan) Corp..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.